# A Randomized Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Safety, Tolerability and Potential Effects of the Dietary Supplement Violet™ Molecular Iodine (I2) on Breast Health in Women With Cyclic Breast Discomfort and Tenderness

> **NCT02676336** · NA · COMPLETED · sponsor: **BioPharmX, Inc.** · enrollment: 31 (actual)

## Conditions studied

- Fibrocystic Breast Condition (FBC)

## Interventions

- **DIETARY_SUPPLEMENT:** Violet™ Molecular Iodine (I2)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02676336
- **Lead sponsor:** BioPharmX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2018-01-31
- **Final completion:** 2018-01-31
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02676336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02676336, "A Randomized Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Safety, Tolerability and Potential Effects of the Dietary Supplement Violet™ Molecular Iodine (I2) on Breast Health in Women With Cyclic Breast Discomfort and Tenderness". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02676336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*